Animal |
Common species for study: rats, mice, non-human primates, sheep, and guinea pigs
When translating findings: genetic similarities/differences to humans, polytocous and altricial species, proportional translation of intervention/exposure to humans
Timing of exposure, e.g. initiation prior to conception, early in gestation, or throughout gestation? Include weaning?
|
Low genetic variability + genetic models (knockdowns, knockouts, transgenics)
Highly controlled conditions (sleep cycle, diet, exercise, stress, etc.)
Implementation of adverse intrauterine exposure
Analysis of tissues
Low cost
Shorter gestation compared to human
|
|
Human |
Timing of exposure, e.g. early, middle, late or all of gestation, breastfeeding
Tissue specific epigenetic signatures
|
Translational findings
Public health relevance
|
High interindividual variability
Lifestyle (un/healthy) effects on development of disease and modifications of epigenome
Ethical considerations for implementing/observing adverse intrauterine exposures and studying vulnerable populations
Limited tissue access
|
Unknown Exposure Retrospective
|
|
Large sample size
Low cost
|
Assumption of birth outcome correlating to adverse exposure
Lack of causative evidence
Reliance on medical records and/or self-report
|
Known Exposure Retrospective
|
|
|
|
Prospective and Retrospective
|
|
Ability for in vivo assessments such as body composition, insulin sensitivity, methylation patterns, etc.
|
|
Longitudinal
|
|
|
|
Interventional
|
Mendelian randomization
Past exposures and current epigenome
Parallel or crossover design
Timing of intervention
Intervention must be generally regarded as safe
|
|
High cost
Resource intensive
|